Claudia Campani

机构：Inserm, Université Paris Cité, Sorbonne Université, Université Sorbonne Paris Nord, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Centre de Recherche Saint-Antoine, University of Florence · ORCID：0000-0003-3842-782X

发表论文 153 篇 · 总被引 1569 次 · h-index 21

代表论文

• Tumor-based biomarkers and circulating tumor DNA for precision medicine in advanced hepatocellular carcinoma (2025 · Clinical and Molecular Hepatology · 被引 9)
• Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma (2025 · Cell Reports Medicine · 被引 7)
• Survival in patients receiving reduced dose intensity of bevacizumab for unresectable hepatocellular carcinoma (2025 · npj Precision Oncology · 被引 7)
• Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab (2025 · Liver International · 被引 6)
• Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 5)
• Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study (2025 · Hepatology International · 被引 5)